Dublin, Sept. 04, 2023 (GLOBE NEWSWIRE) -- The "Label Free Detection Market by Product & Service (Instruments, Consumables (Biosensor Chips, Microplates), Software), Technology (Surface Plasmon Resonance), Application (Hit Confirmation, Lead Generation), End User (Pharma, CROs) & Region - Global Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.
The global label-free detection market is projected to reach USD 863 million by 2028 from USD 570 million in 2023, at a CAGR of 8.7% during the forecast period of 2023 to 2028
The label-free detection market is witnessing remarkable growth propelled by a convergence of factors driving advancements in scientific research. Technological breakthroughs have led to the introduction of sophisticated products, revolutionizing the landscape of research and discovery.
Concurrently, the synergy between academic and industrial entities is spearheading drug discovery programs, fostering innovation through diverse collaborations. The high sensitivity of label-free technologies further enhances their appeal in the scientific community. However, this journey is not without challenges, as the market contends with the hurdle of instrument costs impacting its growth trajectory.
Amidst these dynamics, industry-academia partnerships emerge as key enablers, exemplified by collaborations like Waters Corporation's alliance with Princeton University. This union exemplifies how academia and industry are harmonizing their expertise to solve complex scientific challenges.
Such transformative initiatives pave the way for the evolution of the label-free detection market, supported by prominent players at its forefront, including Danaher Corporation, Sartorius AG, Waters Corporation, PerkinElmer Inc., and AMETEK, Inc.
The biosensor chips segment accounted for the largest share by consumables during the forecast period
In 2022, biosensor chips segment accounted for the largest share by consumables in the global label-free detection market. Biosensors are important tools in the fields of biochemistry and biomedical engineering because they provide a platform for the detection of various analytes.
Currently, label-free biosensors are widely used in proteomics and biomolecular interaction studies, as the detection of the chemical or biological agent by the transducer does not rely on dyes, enzymes, or radiolabels. Conventionally, many small molecules are detected by chromatographic methods, which are usually costly, bulky, and require expertise.
Biosensors offer a cheaper and faster alternative. Some advantages of biosensors over classical methods for small-molecule detection include real-time monitoring, high specificity, fast response times, reduced consumption of organic solvents and sample manipulation, portability, compactness, and easy operation.
Europe accounted for the second-largest market for label-free detection market after North America
The European label-free detection market has witnessed significant growth in recent years, driven by various factors that have propelled its expansion. Europe is at the forefront of developing and adopting emerging technologies in the field of label-free detection market. This includes advancements in label-free detection technologies.
The adoption of these innovative technologies accelerates the progress of viral vector and plasmid DNA manufacturing research and expands its applications. Additionally, Europe offers comprehensive training and education programs in label-free detection technologies.
Universities, research institutes, and organizations provide funding, and conferences to enhance the knowledge and skills of scientists and researchers. The availability of funding promotes the adoption and utilization of of label-free detection technologies in Europe.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 251 |
| Forecast Period | 2023 - 2028 |
| Estimated Market Value (USD) in 2023 | $570 Million |
| Forecasted Market Value (USD) by 2028 | $863 Million |
| Compound Annual Growth Rate | 8.7% |
| Regions Covered | Global |
Premium Insights
- Growing Number of Drug Discovery Programs to Drive Market
- Instruments Dominated North American Label-Free Detection Market in 2022
- Pharmaceutical & Biotechnology Companies Segment Accounted for Largest Share of APAC Market in 2022
- Pharmaceutical & Biotechnology Companies Accounted for Largest Market Share in 2022
- Asia-Pacific Countries to Register Highest Growth Rate in Label-Free Detection Market from 2023 to 2028
Market Dynamics
Drivers
- Technological Advancements in Label-Free Detection
- Growing Academic-Industrial Partnerships for Drug Discovery Programs
- High Sensitivity of Label-Free Technologies
Restraints
- High Cost of Instruments
Opportunities
- Growing Life Sciences Research in Emerging Economies
Challenges
- Sample Complexity and Interference
Trends
- Rising Pharmaceutical Outsourcing
- Increasing Applications of Label-Free Electrochemical Sensing Platforms
Company Profiles
Key Players
- Danaher
- Sartorius AG
- Waters Corporation
- Perkinelmer, Inc.
- Ametek, Inc.
- Horiba, Ltd.
- Spectris
- Mettler Toledo International, Inc.
- Agilent Technologies, Inc.
- Shimadzu Corporation
- Hitachi High-Tech Corporation
- Attana Ab
- Bruker
Other Players
- Nanotemper Technologies GmbH
- Affinite Instruments
- Biosensing Instrument
- Unchained Labs
- Bionavis Ltd.
- Carterra, Inc.
- Nicoya
- Bioptix Analytical LLC
- Plexera Bioscience
- Xantec Bioanalytics GmbH
- Lino Biotech AG (Miltenyi Biotec)
- Kep Technologies
For more information about this report visit https://www.researchandmarkets.com/r/hsenqx
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
